Metabolomic strategies to study lipotoxicity in cardiovascular disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 3, 2010, Pages 230-234

  Waterman, Claire L ^a   Kian Kai, Cheng ^a   Griffin, Julian L ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ApoE; Atherosclerosis; Coronary artery disease; Metabonomic; Myocardial infarction; Systems biology

Indexed keywords

ADENOSINE; ALANINE; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; PYRIMIDINE; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIET; DISEASE COURSE; DYSLIPIDEMIA; GENOME; HEART INFARCTION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPIDOSIS; METABOLIC DISORDER; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE TRAIT LOCUS; REVIEW; TRANSCRIPTOMICS;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIPID METABOLISM; MALE; METABOLOMICS;

EID: 76049119419     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.11.004     Document Type: Review

References (29)

1. Oliver S.G., Winson M.K., Kell D.B., and Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 16 (1998) 373-378
2. Tweeddale H., Notley-McRobb L., and Ferenci T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis. J. Bacteriol. 180 (1998) 5109-5116
3. Fiehn O., Kopka J., Dormann P., Altmann T., Trethewey R.N., and Willmitzer L. Metabolite profiling for plant functional genomics. Nat. Biotechnol. 18 (2000) 1157-1161
4. Nicholson J.K., Lindon J.C., and Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999) 1181-1189
5. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19 (1999) 1720-1730
6. Atherton H.J., Bailey N.J., Zhang W., Taylor J., Major H., Shockcor J., Clarke K., and Griffin J.L. A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol. Genomics 27 2 (2006) 178-186
7. Dumas M.E., Wilder S.P., Bihoreau M.T., Barton R.H., Fearnside J.F., Argoud K., D'Amato L., Wallis R.H., Blancher C., Keun H.C., Baunsgaard D., Scott J., Sidelmann U.G., Nicholson J.K., and Gauguier D. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat. Genet. 39 5 (2007) 666-672
8. Toye A.A., Dumas M.E., Blancher C., Rothwell A.R., Fearnside J.F., Wilder S.P., Bihoreau M.T., Cloarec O., Azzouzi I., Young S., Barton R.H., Holmes E., McCarthy M.I., Tatoud R., Nicholson J.K., Scott J., and Gauguier D. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 50 9 (2007) 1867-1879
9. Jawien J., Nastalek P., and Korbut R. Mouse models of experimental atherosclerosis. J. Physiol. Pharmacol. 55 (2004) 503-517
10. Breslow J.L. Mouse models of atherosclerosis. Science 272 (1996) 685-688
11. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93 (1994) 1885-1893
12. Griffin J.L., Williams H.J., Sang E., Clarke K., Rae C., and Nicholson J.K. Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal. Biochem. 293 1 (2001) 16-21
13. Jones G.L., Sang E., Goddard C., Mortishire-Smith R.J., Sweatman B.C., Haselden J.N., Davies K., Grace A.A., Clarke K., and Griffin J.L. A functional analysis of mouse models of cardiac disease through metabolic profiling. J. Biol. Chem. 280 9 (2005) 7530-7539
14. Clish C.B., Davidov E., Oresic M., Plasterer T.N., Lavine G., Londo T., Meys M., Snell P., Stochaj W., Adourian A., Zhang X., Morel N., Neumann E., Verheij E., Vogels J.T., Havekes L.M., Afeyan N., Regnier F., van der Greef J., and Naylor S. Integrative biological analysis of the APOE*3-leiden transgenic mouse. Omics 8 (2004) 3-15
15. Mayr M., Chung Y.-L., Mayr U., Yin X., Ly L., Troy H., Fredericks S., Hu Y., Griffiths J.R., and Xu Q. Proteomic and metabolomic analysis of atherosclerotic vessels from Apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 25 (2006) 2135-2142
16. Kleemann R., Verschuren L., van Erk M.J., Nikolsky Y., Cnubben N.H., Verheij E.R., Smilde A.K., Hendriks H.F., Zadelaar S., Smith G.J., Kaznacheev V., Nikolskaya T., Melnikov A., Hurt-Camejo E., van der Greef J., van Ommen B., and Kooistra T. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol. 8 9 (2007) R200
17. Atherton H.J., Gulston M.K., Bailey N.J., Cheng K.K., Zhang W., Clarke K., and Griffin J.L. Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol. Syst. Biol. 5 (2009) 259
18. Brindle J.T., Antti H., Holmes E., Tranter G., Nicholson J.K., Bethell H.W., Clarke S., Schofield P.M., McKilligin E., Mosedale D.E., and Grainger D.J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8 12 (2002) 1439-1444
19. Brindle J.T., Nicholson J.K., Schofield P.M., Grainger D.J., and Holmes E. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 128 1 (2003) 32-36
20. Kirschenlohr H.L., Griffin J.L., Clarke S.C., Rhydwen R., Grace A.A., Schofield P.M., Brindle K.M., and Metcalfe J.C. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat. Med. 12 6 (2006) 705-710
21. Marre M., Lievre M., Chatellier G., Mann J.F., Passa P., Ménard J., and DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 328 7438 (2004) 495
22. Roussel R., Mentré F., Bouchemal N., Hadjadj S., Lièvre M., Chatellier G., Menard J., Panhard X., Le Hénanff A., Marre M., and Le Moyec L. DIABHYCAR Study Group. NMR-based prediction of cardiovascular risk in diabetes. Nat. Med. 13 4 (2007) 399-400
23. Mäkinen V.P., Soininen P., Forsblom C., Parkkonen M., Ingman P., Kaski K., Groop P.H., Ala-Korpela M., and FinnDiane Study Group. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol. Syst. Biol. 4 (2008) 167
24. Lewis G.D., Wei R., Liu E., Yang E., Shi X., Martinovic M., Farrell L., Asnani A., Cyrille M., Ramanathan A., Shaham O., Berriz G., Lowry P.A., Palacios I.F., Taşan M., Roth F.P., Min J., Baumgartner C., Keshishian H., Addona T., Mootha V.K., Rosenzweig A., Carr S.A., Fifer M.A., Sabatine M.S., and Gerszten R.E. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J. Clin. Invest. 118 10 (2008) 3503-3512
25. Shah S.H., Hauser E.R., Bain J.R., Muehlbauer M.J., Haynes C., Stevens R.D., Wenner B.R., Dowdy Z.E., Granger C.B., Ginsburg G.S., Newgard C.B., and Kraus W.E. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol. Syst. Biol. 5 (2009) 258
26. M. Orešiča, Systems biology strategy to study lipotoxicity and the metabolic syndrome, Biochim. Biophys. Acta (2009), doi:10.1016/j.bbalip.2009.11.003.
27. Kotronen A., Velagapudi V.R., Yetukuri L., Westerbacka J., Bergholm R., Ekroos K., Makkonen J., Taskinen M.R., Oresic M., and Yki-Jarvinen H. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52 4 (2009) 684-690
28. Kolak M., Westerbacka J., Velagapudi V.R., Wagsater D., Yetukuri L., Makkonen J., Rissanen A., Hakkinen A.M., Lindell M., Bergholm R., Hamsten A., Eriksson P., Fisher R.M., Oresic M., and Yki-Jarvinen H. Adipose tissue inflammation and increased ceramide content characterise subjects with high liver fat content independent of obesity. Diabetes 56 8 (2007) 1960-1968
29. McCombie G., Browning L.M., Titman C.M., Song M., Shockcor J., Jebb S.A., and Griffin J.L. W-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics 5 3 (2009) 363-374